# Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia

> **NCT05892770** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Florida** · enrollment: 36 (estimated)

## Conditions studied

- Spasmodic Dysphonia

## Interventions

- **DRUG:** Zinc gluconate supplement
- **DRUG:** Botulinum toxin type A

## Key facts

- **NCT ID:** NCT05892770
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2025-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05892770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05892770, "Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05892770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*